Skip to navigation Skip to content
Active Featured

Active Featured

Medication News Analysis

  • Hematology
  • Neuroscience
  • Nutrition
  • Nanomedicine
Active Featured
  • Home
  • About Us
  • Contact Us
  • Our Team
  • Terms of Service
  • Privacy Policy
Active Featured

Active Featured

Medication News Analysis

  • Hematology
  • Neuroscience
  • Nutrition
  • Nanomedicine

Tag: CR or PR

  • Home
  • CR or PR
January 18, 20200

In Relapsed Chronic Lymphocytic Leukemia Ofatumumab May Extend Linger

Ofatumumab support treatment seems to delay movement free endurance (PFS) in patients with backslid constant lymphocytic leukemia (CLL), as indicated

Read More

Recent Posts

  • The Global Demand of Americas Hematology Diagnostics Market, Growth Analysis, Latest Trends and Forecast till 2031
  • Research and Technological Innovations to Bolster Developments in Bioactive Materials Market
  • Ballistic Composites Market Globally Expected to Drive Growth through 2027
  • Automotive Composites Market Expected to Expand at a Steady CAGR through 2031
  • Wireless Portable Medical Devices Market Global Industry Analysis and Forecast Till 2031

Categories

  • Cloud PRwire
  • Hematology
  • Nanomedicine
  • Neuroscience
  • Nutrition
  • Press Release
WordPress Theme : VMagazine Lite